Cargando…
Young patients’ involvement in a composite endpoint method development on acceptability for paediatric oral dosage forms
BACKGROUND: In line with the European Paediatric Regulation, the European Medicines Agency (EMA) asks for investigation of a medicine’s acceptability in paediatric medicines development. A standardised acceptability testing method combining the outcome of “swallowability” and “palatability” assessme...
Autores principales: | Reidemeister, Sibylle, Nafria Escalera, Begonya, Marín, Daniel, Balayla, Jan, Klingmann, Ingrid, Klingmann, Viviane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688476/ https://www.ncbi.nlm.nih.gov/pubmed/38031172 http://dx.doi.org/10.1186/s40900-023-00520-8 |
Ejemplares similares
-
A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population
por: Wargenau, Manfred, et al.
Publicado: (2022) -
Dosage Forms Suitability in Pediatrics: Acceptability of Analgesics and Antipyretics in a German Hospital
por: Klingmann, Viviane, et al.
Publicado: (2022) -
Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study
por: Münch, Juliane, et al.
Publicado: (2023) -
Children’s Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure)
por: Alessandrini, Elisa, et al.
Publicado: (2021) -
Reporting involvement activities with children and young people in paediatric research: a framework analysis
por: Preston, Jennifer, et al.
Publicado: (2023)